This invention relates to potent selective agonists of the EP.sub.4 subtype of prostaglandin E2 receptors of formula (1), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of the patient. 1

 
Web www.patentalert.com

< Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation

< Novel maxi-k channel blockers, methods of use and process for making the same

> 2 Methoxy antimycin a derivatives and methods of use

> Pharmaceutical compositions useful in prevention and treatment of beta-amyloid protien-induced disease

~ 00217